633 related articles for article (PubMed ID: 24259642)
1. Intravenous warfarin and heparin-induced thrombocytopenia: making the diagnosis, management, modern monitoring, and multidisciplinary care.
Burger CF; Schlesinger JJ
Ann Pharmacother; 2014 Feb; 48(2):286-91. PubMed ID: 24259642
[TBL] [Abstract][Full Text] [Related]
2. Recognition of heparin-induced thrombocytopenia and initiation of argatroban therapy after cardiothoracic surgery in the intensive care unit.
Demma LJ; Paciullo CA; Levy JH
J Thorac Cardiovasc Surg; 2012 May; 143(5):1213-8. PubMed ID: 22329977
[TBL] [Abstract][Full Text] [Related]
3. Prolonged anticoagulation after discontinuation of argatroban and warfarin therapy in an obese patient with heparin-induced thrombocytopenia.
Shapiro NL; Durr EA; Krueger CD
Pharmacotherapy; 2006 Dec; 26(12):1806-10. PubMed ID: 17125442
[TBL] [Abstract][Full Text] [Related]
4. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia.
Lewis BE; Wallis DE; Leya F; Hursting MJ; Kelton JG;
Arch Intern Med; 2003 Aug 11-25; 163(15):1849-56. PubMed ID: 12912723
[TBL] [Abstract][Full Text] [Related]
5. Transitioning from argatroban to warfarin therapy in patients with heparin-induced thrombocytopenia.
Hursting MJ; Lewis BE; Macfarlane DE
Clin Appl Thromb Hemost; 2005 Jul; 11(3):279-87. PubMed ID: 16015413
[TBL] [Abstract][Full Text] [Related]
6. Use of argatroban as a procedural and bridging anticoagulant in a patient undergoing carotid endarterectomy with concomitant atrial fibrillation.
Nanda MM; Kauflin MJ; Jain PG; Yannetta JC
Ann Pharmacother; 2011 Mar; 45(3):e16. PubMed ID: 21386022
[TBL] [Abstract][Full Text] [Related]
7. Heparin-Induced Thrombocytopenia in Infants after Heart Surgery.
Abdillah JN; Hu Q; Chen X; Chen X; Zhou W; Luo W; Huang L
Thorac Cardiovasc Surg; 2019 Jan; 67(1):21-27. PubMed ID: 29605959
[TBL] [Abstract][Full Text] [Related]
8. Current agents for the treatment of patients with heparin-induced thrombocytopenia.
Warkentin TE
Curr Opin Pulm Med; 2002 Sep; 8(5):405-12. PubMed ID: 12172444
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulation with Novastan (argatroban) in patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome.
Lewis BE; Walenga JM; Wallis DE
Semin Thromb Hemost; 1997; 23(2):197-202. PubMed ID: 9200347
[TBL] [Abstract][Full Text] [Related]
10. Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD.
Dager WE; White RH
Ann Pharmacother; 2003 Sep; 37(9):1232-6. PubMed ID: 12921505
[TBL] [Abstract][Full Text] [Related]
11. Use of argatroban and catheter-directed thrombolysis with alteplase in an oncology patient with heparin-induced thrombocytopenia with thrombosis.
Dee B; Lombardi Thomas L; Gulbis A
Am J Health Syst Pharm; 2014 May; 71(9):711-6. PubMed ID: 24733133
[TBL] [Abstract][Full Text] [Related]
12. Argatroban for prevention and treatment of thromboembolism in heparin-induced thrombocytopenia.
Kondo LM; Wittkowsky AK; Wiggins BS
Ann Pharmacother; 2001 Apr; 35(4):440-51. PubMed ID: 11302409
[TBL] [Abstract][Full Text] [Related]
13. Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban.
Warkentin TE
Thromb Res; 2003 May; 110(2-3):73-82. PubMed ID: 12893020
[TBL] [Abstract][Full Text] [Related]
14. Treatment of pulmonary embolism with argatroban and ultrasound-assisted catheter-directed thrombolysis with alteplase in a patient with heparin-induced thrombocytopenia.
Bethea BT; Elliot JW; Richardson JB; Ahmed MI
Am J Health Syst Pharm; 2017 Aug; 74(15):1153-1157. PubMed ID: 28743779
[TBL] [Abstract][Full Text] [Related]
15. A randomized, open-label pilot study comparing desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis: PREVENT-HIT Study.
Boyce SW; Bandyk DF; Bartholomew JR; Frame JN; Rice L
Am J Ther; 2011 Jan; 18(1):14-22. PubMed ID: 21079512
[TBL] [Abstract][Full Text] [Related]
16. High-dose argatroban for treatment of heparin-induced thrombocytopenia with thrombosis: a case report and review of laboratory considerations.
Hellwig TR; Peitz GJ; Gulseth MP
Am J Health Syst Pharm; 2012 Mar; 69(6):490-5. PubMed ID: 22382479
[TBL] [Abstract][Full Text] [Related]
17. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
Jeske WP; Walenga JM
Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410
[TBL] [Abstract][Full Text] [Related]
18. Evolving management strategies for heparin-induced thrombocytopenia.
Rice L
Semin Hematol; 2005 Jul; 42(3 Suppl 3):S15-21. PubMed ID: 16105554
[TBL] [Abstract][Full Text] [Related]
19. Transitioning from argatroban to warfarin in heparin-induced thrombocytopenia: an analysis of outcomes in patients with elevated international normalized ratio (INR).
Bartholomew JR; Hursting MJ
J Thromb Thrombolysis; 2005 Jun; 19(3):183-8. PubMed ID: 16082605
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for major bleeding in patients with heparin-induced thrombocytopenia treated with argatroban: a retrospective study.
Hursting MJ; Verme-Gibboney CN
J Cardiovasc Pharmacol; 2008 Dec; 52(6):561-6. PubMed ID: 19057393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
